Hepatology· 2023Q1
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
- 2,959citations
- Q1SCImago
- 2023year
Short summary
A Delphi consensus involving 236 experts and patient advocates recommends replacing NAFLD/NASH with 'metabolic dysfunction-associated steatotic liver disease' (MASLD) and 'metabolic dysfunction-associated steatohepatitis' (MASH) to reduce stigma and improve identification. The new definition requires at least one cardiometabolic risk factor.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Epidemiology
EpidemiologyMedicine